Patent ID: 11965025
Assignee: MARENGO THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 17:
18. The method of claim 1, wherein
(i) the cytokine is a human IL-2 having a sequence with at least 95% sequence identity to a sequence selected from the group consisting of SEQ ID NOs: 2191, 2270, 2280,
(ii) the cytokine is a human IL-15 having a sequence with at least 95% sequence identity to a sequence selected from the group consisting of SEQ ID NOs: 2170 and 2320, or
(iii) the cytokine is a human IL-21 having a sequence with at least 95% sequence identity to SEQ ID NO: 2193.